Titan Announces Conavi Medical to Present Overview at Titan Q&A Session Page 1

TORONTO, Ontario, September 16, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan(TSX: TMD; OTC: TMDIF) announces that Conavi Medical Inc. (“Conavi”) will participate in the previously announced Titan Q&A session to be held on Thursday, September 19, 2024 at 5:00 p.m. ET in connection with the proposed business combination between Titan and Conavi to be discussed at Titan’s annual general meeting on September 30, 2024. Following Conavi’s presentation, Titan will provide prepared remarks followed by a Q&A session. Paul Cataford, Interim President and CEO, and Chien Huang, Chief Financial Officer, will attend the session on behalf of Titan.

Shareholders are invited to submit questions prior to the Q&A session via [email protected]. Questions will be accepted until September 17, 2024, 1:00 PM ET. A link to the live audio webcast will be made available in the Investors Relations section of the Company’s website, www.titanmedicalinc.com.